PAVmed Statistics

Share Statistics

PAVmed has 17.29M shares outstanding. The number of shares has increased by 66.19% in one year.

Shares Outstanding	17.29M
Shares Change (YoY)	66.19%
Shares Change (QoQ)	3.02%
Owned by Institutions (%)	0.01%
Shares Floating	14.21M
Failed to Deliver (FTD) Shares	2,379
FTD / Avg. Volume	1.48%

Short Selling Information

The latest short interest is 229.83K, so 1.33% of the outstanding shares have been sold short.

Short Interest	229.83K
Short % of Shares Out	1.33%
Short % of Float	1.61%
Short Ratio (days to cover)	2.05

Valuation Ratios

The PE ratio is 0.15 and the forward PE ratio is -1.2. PAVmed's PEG ratio is 0.

PE Ratio	0.15
Forward PE	-1.2
PS Ratio	2.03
Forward PS	10.5
PB Ratio	0
P/FCF Ratio	-0.18
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for PAVmed.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.06, with a Debt / Equity ratio of -0.01.

Current Ratio	0.06
Quick Ratio	0.06
Debt / Equity	-0.01
Debt / EBITDA	1.07
Debt / FCF	-0.95
Interest Coverage	-988.6

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$76.79K
Profits Per Employee	$1.02M
Employee Count	39
Asset Turnover	0.1
Inventory Turnover	22.7

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -46.15% in the last 52 weeks. The beta is 1.08, so PAVmed's price volatility has been higher than the market average.

Beta	1.08
52-Week Price Change	-46.15%
50-Day Moving Average	0.55
200-Day Moving Average	0.69
Relative Strength Index (RSI)	55.11
Average Volume (20 Days)	160,466

Income Statement

In the last 12 months, PAVmed had revenue of 3M and earned 39.79M in profits. Earnings per share was 3.3.

Revenue	3M
Gross Profit	-3.04M
Operating Income	-44.49M
Net Income	39.79M
EBITDA	29.67M
EBIT	28.47M
Earnings Per Share (EPS)	3.3

Full Income Statement

Balance Sheet

The company has 1.19M in cash and 31.86M in debt, giving a net cash position of -30.68M.

Cash & Cash Equivalents	1.19M
Total Debt	31.86M
Net Cash	-30.68M
Retained Earnings	-254.97B
Total Assets	52.82B
Working Capital	-6.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.55M and capital expenditures -55K, giving a free cash flow of -33.61M.

Operating Cash Flow	-33.55M
Capital Expenditures	-55K
Free Cash Flow	-33.61M
FCF Per Share	-3.47

Full Cash Flow Statement

Margins

Gross margin is -101.6%, with operating and profit margins of -1485.38% and 1328.58%.

Gross Margin	-101.6%
Operating Margin	-1485.38%
Pretax Margin	949.15%
Profit Margin	1328.58%
EBITDA Margin	990.65%
EBIT Margin	-1485.38%
FCF Margin	-1122.17%

Dividends & Yields

PAVM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for PAVM is $19, which is 3777.6% higher than the current price. The consensus rating is "Buy".

Price Target	$19
Price Target Difference	3777.6%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Dec 7, 2023. It was a backward split with a ratio of 1:15.

Last Split Date	Dec 7, 2023
Split Type	backward
Split Ratio	1:15

Scores

Altman Z-Score	-6.42
Piotroski F-Score	2

PAVmed Inc. (PAVM)